|
|
Soapbox
By Charlie Kim, Soom The regulation is bringing digital enablement to the forefront, requiring electronic instructions for use. |
Featured Articles |
By Maria Fontanazza, Editor-in-Chief According to the FDA, more than 90% of products sterilized at the facility are medical devices. |
By MedTech Intelligence Staff The resignation will be effective in about a month, according to reports. |
|
Featured Quote — Susan Niemeier, Ivenix |
|
|||
Sponsored Content |
Join us to learn about the Siemens Digital Enterprise Framework for Intelligent Design Control: an integrated, systematic, logical system for building & maintaining product design control for medical devices, integrating requirements & risk management, test planning & execution, and design output management, including Design History Files and Device Master Records |
|
|
Resource Centers |
Resource Centers are single topic focused micro-sites within MedTechIntelligence.com that are portals of information on medical device components and quality systems offering news, articles, white papers, case histories and videos. |
|
Sponsored Resources |
There are many steps involved in the process of bringing a device to market, especially examining the regulatory environment in which medical device customers operate. Depending on your device, its indications or the presence of drug or biologic components, submissions to the U.S. FDA, EU Notified Bodies or Competent Authorities, and other regulatory bodies might be considered, but if you're using a component as a layer between other components of your medical device, or if you're using a component to adhere a device to skin, more may be expected from you by the FDA or other regulatory agency reviewers. When adhering a device to skin special attention should be given to the final, finished device composition and biocompatibility, inclusive of all component(s). |
Upcoming Events & Webinars |
|